Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
7.61
Dollar change
-0.23
Percentage change
-2.93
%
IndexRUT P/E- EPS (ttm)-0.61 Insider Own8.75% Shs Outstand207.12M Perf Week1.47%
Market Cap1.53B Forward P/E- EPS next Y-0.09 Insider Trans-0.11% Shs Float189.00M Perf Month-1.55%
Income-123.82M PEG- EPS next Q-0.07 Inst Own78.74% Short Float9.78% Perf Quarter-0.78%
Sales412.58M P/S3.71 EPS this Y68.26% Inst Trans-1.43% Short Ratio9.48 Perf Half Y20.60%
Book/sh-2.26 P/B- EPS next Y76.21% ROA-24.42% Short Interest18.49M Perf Year38.11%
Cash/sh1.65 P/C4.62 EPS next 5Y44.80% ROE- 52W Range4.03 - 8.88 Perf YTD27.05%
Dividend Est.- P/FCF- EPS past 5Y-3.73% ROI-36.67% 52W High-14.30% Beta1.77
Dividend TTM- Quick Ratio2.73 Sales past 5Y190.00% Gross Margin97.73% 52W Low88.83% ATR (14)0.39
Dividend Ex-Date- Current Ratio2.78 EPS Y/Y TTM51.59% Oper. Margin-9.87% RSI (14)51.36 Volatility6.00% 5.14%
Employees536 Debt/Eq- Sales Y/Y TTM29.92% Profit Margin-30.01% Recom1.18 Target Price14.82
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q64.43% Payout- Rel Volume0.87 Prev Close7.84
Sales Surprise2.71% EPS Surprise-1.60% Sales Q/Q34.98% EarningsNov 04 BMO Avg Volume1.95M Price7.61
SMA201.68% SMA500.33% SMA20014.32% Trades Volume1,686,832 Change-2.93%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Overweight $10
Sep-18-23Upgrade RBC Capital Mkts Sector Perform → Outperform $9 → $10
Aug-04-23Upgrade Jefferies Hold → Buy $11
Jul-13-23Upgrade BofA Securities Neutral → Buy $10
Feb-22-23Upgrade Needham Hold → Buy $14
Nov-02-22Upgrade Evercore ISI In-line → Outperform $14 → $16
Aug-05-22Downgrade Oppenheimer Outperform → Perform
Aug-05-22Downgrade Evercore ISI Outperform → In-line $14
Apr-18-22Downgrade Barclays Overweight → Equal Weight $22 → $13
Apr-11-22Downgrade BofA Securities Buy → Neutral $21 → $14
Dec-04-24 04:15PM
Nov-18-24 02:00AM
Nov-06-24 07:00AM
Nov-05-24 07:29AM
07:00AM
02:32AM Loading…
02:32AM
02:03AM
Nov-04-24 02:30PM
08:10AM
07:06AM
07:00AM
Oct-24-24 08:00AM
Oct-23-24 09:55AM
Oct-21-24 07:00AM
Oct-17-24 03:05PM
07:00AM Loading…
Oct-14-24 07:00AM
Oct-11-24 12:15PM
Oct-10-24 07:00AM
Oct-09-24 08:03AM
Oct-07-24 12:00PM
Oct-03-24 07:00AM
Oct-02-24 07:00AM
Oct-01-24 07:30AM
06:53AM
Sep-30-24 07:00AM
Sep-17-24 07:00AM
Sep-12-24 01:25AM
Sep-06-24 02:00AM
Sep-05-24 07:00AM
Sep-04-24 07:00AM
07:00AM Loading…
Aug-22-24 07:00AM
Aug-06-24 08:45AM
Aug-05-24 01:00PM
09:55AM
08:10AM
07:06AM
07:00AM
Aug-02-24 07:00AM
Jul-30-24 12:25PM
Jul-29-24 10:00AM
Jul-22-24 07:00AM
Jul-18-24 12:00PM
09:55AM
Jul-10-24 04:32AM
Jul-09-24 07:00AM
Jul-02-24 07:00AM
Jun-04-24 07:00AM
Jun-02-24 04:00AM
May-15-24 01:13PM
11:00AM
11:00AM
11:00AM
11:00AM
May-14-24 07:00AM
May-13-24 10:31AM
07:00AM
May-09-24 07:00AM
May-07-24 11:51AM
10:50AM
07:00AM
03:01AM
01:13AM
May-06-24 06:47PM
04:59PM
01:00PM
12:35PM
12:35PM
11:53AM
11:45AM
08:32AM
08:10AM
07:10AM
07:00AM
May-03-24 07:00AM
Apr-29-24 10:00AM
Apr-22-24 07:00AM
Apr-17-24 05:14AM
04:30AM
Apr-10-24 06:09PM
Apr-03-24 07:00AM
Mar-25-24 04:01PM
Mar-13-24 07:07AM
Mar-05-24 07:01AM
Mar-01-24 08:29AM
Feb-28-24 10:47AM
Feb-27-24 04:05AM
Feb-26-24 04:45PM
08:10AM
07:32AM
07:09AM
07:00AM
Feb-23-24 07:00AM
Feb-21-24 04:01PM
Feb-19-24 07:54AM
Feb-12-24 07:00AM
Feb-05-24 07:00AM
Feb-02-24 07:00AM
Jan-09-24 09:25AM
Jan-05-24 04:01PM
Jan-03-24 04:01PM
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKee Amy EDirectorJun 24 '24Sale6.328,60054,35227,831Jun 25 04:39 PM
SANDERS MACHELLEDirectorJun 17 '24Sale6.004,68928,13427,742Jun 17 04:31 PM
HEGGIE THERESADirectorJun 14 '24Sale6.116,69840,92552,852Jun 14 04:25 PM
LEVIN ALAN GDirectorMay 30 '24Buy6.367,86149,99644,951May 31 04:25 PM
ASELAGE STEVEDirectorMay 24 '24Buy6.402,50016,0002,500May 29 04:16 PM
Hutson Nancy JDirectorMay 20 '24Buy6.385,00031,90086,818May 22 07:24 AM
MILANO VINCENTDirectorMay 20 '24Buy6.2515,00093,75066,997May 22 07:21 AM
Doyle AnthonyChief Financial OfficerMay 14 '24Buy5.5736,300202,191266,744May 15 07:19 AM
Thackray Helen M.Chief R&D OfficerMay 14 '24Buy5.8630,000175,800272,139May 15 07:17 AM
Galson Steven KDirectorMay 13 '24Buy5.4921,940120,45151,551May 15 07:14 AM
Barnes Alane PChief Legal OfficerMay 13 '24Buy5.535,00027,650300,762May 15 07:11 AM
Stonehouse Jon PPresident & CEOMay 13 '24Buy5.5530,000166,5001,127,770May 15 07:08 AM
Gayer Charles KChief Commercial OfficerMay 13 '24Buy5.4730,000164,100307,533May 15 07:04 AM